Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
Prospective evaluation of the carbon footprint and clinical utility of IBUS compared with colonoscopy and enterography in ulcerative colitis…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) [Phase 4]
A Phase 4 clinical trial evaluating the combination of vedolizumab and tofacitinib in adults with Ulcerative Colitis is currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
A clinico-biological collection study designed to investigate the pathophysiology of systemic autoimmune diseases, including systemic lupus …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
A 5-year longitudinal observational study is being conducted on patients receiving therapy for inflammatory bowel disease. The trial is spon…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Zymfentra (Infliximab-dyyb) REal World Cohort STudy
A real-world cohort study of Zymfentra (Infliximab-dyyb) is being conducted by the University of North Carolina, Chapel Hill to evaluate its…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis
A completed clinical trial evaluating the effectiveness and safety of Upadacitinib for acute severe ulcerative colitis reports results on it…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]
A Phase 3 clinical trial comparing risankizumab to vedolizumab in adults with moderate-to-severe ulcerative colitis is currently recruiting …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]
Phase 2 pediatric trial evaluating the long-term safety of intravenous vedolizumab in children with ulcerative colitis or Crohn's disease; r…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis [NA]
A clinical trial is evaluating heart rate variability biofeedback as a treatment for ulcerative colitis. The study is currently not recruiti…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden
Pfizer-sponsored observational study in Sweden will evaluate the real-world effectiveness and treatment adherence of tofacitinib for ulcerat…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Tulisokibart (MK-7240) in participants with moderately to severely active ulcer…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis [Phase 2]
Pfizer is conducting a Phase 2 pediatric trial to evaluate how etrasimod works in children with ulcerative colitis; the study is not yet rec…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease [Phase 2]
Phase 2 clinical trial investigating how the gut microbiota influences host cell energy metabolism in health and in inflammatory bowel disea…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease [Phase 2]
A Phase 2 clinical trial sponsored by Mirador Therapeutics is evaluating therapies for inflammatory bowel disease, including ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: The Role of Secondary Bile Acids in Intestinal Inflammation [Phase 2, Phase 3]
A Stanford-sponsored Phase 2/Phase 3 trial evaluating secondary bile acids for intestinal inflammation in ulcerative colitis and pouchitis h…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: TUDCA as a Therapy for Ulcerative Colitis (UC) [Phase 1]
A Phase 1 clinical trial evaluating tauroursodeoxycholic acid (TUDCA) for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Pfizer is conducting an observational study to learn about long-term use of Velsipity in patients with ulcerative colitis; the study is curr…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Piloting an Insomnia Treatment in Patients With Ulcerative Colitis [NA]
A clinical trial is being piloted to treat insomnia in patients with ulcerative colitis, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating an oral lyophilized fecal microbiota transplantation to prevent relapse or intestinal inflammation in adul…
-
FDA approval · 2026-03-06FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XELJANZ XR (tofacitinib) from Pfizer Laboratories Div Pfizer Inc, introducing the extended-r…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) [NA]
A completed clinical trial comparing high-definition colonoscopy to dye-sprayed chromo-colonoscopy for colorectal cancer screening in patien…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease [NA]
This clinical trial update describes the development of a self-management intervention intended to improve health outcomes for patients with…
-
EMA approval · 2026-03-05EMA Authorised: Simponi (golimumab) — Janssen Cilag International NV
The European Medicines Agency authorised Simponi (golimumab) for multiple inflammatory conditions including rheumatoid arthritis, psoriatic …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial [Phase 4]
Phase 4 OPTIMIZE trial investigates proactive dosing optimization of infliximab in inflammatory bowel disease using a pharmacokinetic dashbo…